F. Gary Toback
Corporate Officer/Principal bei The University of Chicago
Profil
F.
Gary Toback is a Professor at The University of Chicago since 1985.
He was a Founding Scientist & Consultant at NephRx Corp.
He completed his undergraduate degree at The Trustees of Columbia University in The City of New York and his doctorate at Boston University and New York University.
Aktive Positionen von F. Gary Toback
| Unternehmen | Position | Beginn |
|---|---|---|
| The University of Chicago | Corporate Officer/Principal | 01.01.1985 |
Ehemalige bekannte Positionen von F. Gary Toback
| Unternehmen | Position | Ende |
|---|---|---|
NephRx Corp.
 NephRx Corp. BiotechnologyHealth Technology NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von F. Gary Toback
| The Trustees of Columbia University in The City of New York | Undergraduate Degree |
| New York University | Doctorate Degree |
| Boston University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
NephRx Corp.
NephRx Corp. BiotechnologyHealth Technology NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan. | Health Technology |
